サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1532276

ストレッチマーク治療市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測

Stretch Marks Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ストレッチマーク治療市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測
出版日: 2024年08月08日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界のストレッチマーク治療市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • ストレッチマーク治療市場規模（2024E）：29億米ドル
  • 予測市場価値（2033F）：46億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：5.3%

ストレッチマーク治療市場- レポート範囲：

ストレッチマークは、皮膚の急激な伸展によって発生する一般的な皮膚疾患であり、線条または線条体としても知られています。ストレッチマーク治療市場には、局所治療、レーザー治療、外科的介入など、さまざまな治療オプションが含まれます。これらの治療は、ストレッチマークを目立たなくし、肌の質感を改善することを目的としています。この市場は、美容上の改善を求める個人、専門的な治療を提供するヘルスケアプロバイダー、高度なソリューションを提供する美容クリニックなど、幅広い顧客にサービスを提供しています。市場成長の原動力は、皮膚の美容に対する意識の高まり、ライフスタイルやホルモンの変化によるストレッチマークの有病率の上昇、治療技術の進歩です。

市場促進要因：

世界のストレッチマーク治療市場は、効果的な治療オプションの利用可能性に関する意識の高まりなど、いくつかの重要な要因によって推進されています。妊娠、急激な体重増加、思春期などの要因によるストレッチマークの発生件数の増加が、治療需要の高まりに寄与しています。非侵襲的レーザー治療や強化された局所製剤の開発などの技術の進歩は、有効性と患者の快適性を向上させています。さらに、審美性の向上や美容整形への重点の高まりが市場拡大の原動力となっています。可処分所得の増加や、個人に合わせたスキンケアの傾向の高まりは、さらに市場の成長に寄与しています。

市場抑制要因：

有望な成長見込みがあるにもかかわらず、ストレッチマーク治療市場はコストとアクセシビリティに関する課題に直面しています。レーザー治療や外科的介入などの高度な治療には高額な費用がかかるため、個人によっては利用しにくい場合があります。さらに、治療効果は個人の肌質やストレッチマークの重症度によって異なる可能性があり、患者の満足度や治療結果に影響を及ぼす可能性があります。市場はまた、規制の遵守や、治療の有効性と安全性を検証するための継続的な調査の必要性に関する課題にも直面しています。

市場機会：

ストレッチマーク治療市場は、技術革新、人口動向、消費者の嗜好の進化によって大きな成長機会がもたらされます。高周波や超音波を用いた治療などの新技術の統合により、治療オプションが強化されています。パーソナライズされたスキンケアソリューションへの注目の高まりと低侵襲処置の人気の高まりは、市場プレーヤーに新たな道を開く。戦略的パートナーシップ、研究開発への投資、手頃な価格で効果的な治療のイントロダクションは、新たな機会を活用し、市場のリーダーシップを維持するために不可欠です。

本レポートで扱う主な質問

  • 世界のストレッチマーク治療市場の成長を促す主な要因は何か？
  • さまざまな患者層で採用を促進している治療の種類と用途は何か？
  • 技術の進歩はどのようにストレッチマーク治療市場の競合情勢を変えているのか？
  • ストレッチマーク治療市場に貢献している主要プレーヤーは誰か、また市場の関連性を維持するためにどのような戦略を採用しているか？
  • 世界のストレッチマーク治療市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 治療タイプの革新/開発動向

第4章 重要成功要因

  • ポーターの分析
  • PESTEL分析
  • 皮膚科医/美容外科医、主要国
  • 皮膚科・美容外科クリニック、主要国
  • 地域別美容施術件数
  • 地域別妊娠数
  • 支払者ミックス分析
  • 主要プレーヤーによるプロモーション戦略
  • ヘルスケア費償還と資金調達構造
  • 規制シナリオ
  • 親市場分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • ダイナミクス

第6章 COVID-19危機- 影響評価

  • COVID-19と影響分析
    • 治療の種類別
    • ストレッチマークの種類別
    • エンドユーザー別
    • 地域別
  • 2023年の市場シナリオ

第7章 世界市場の需要（金額または規模）分析

  • 市場金額分析、2019～2023年
  • 市場金額予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 治療タイプ別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 外用薬
      • ジェル
      • クリーム
      • オイル/美容液
    • 施術的治療
      • 高周波療法
      • 非切除型レーザーフラクショナルリサーフェシング
      • アブレーションレーザーリサーフェシング
      • 赤外線デバイス/放射線
      • 皮膚剥離
      • ケミカルピーリング
  • 治療タイプ別の市場の魅力分析

第9章 ストレッチマークタイプ別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 萎縮性皮膚線条（皮膚の薄化）
    • ストレッチマーク条（妊娠後）
    • 皮膚の伸展線
    • ストライアルブラエ（赤）
    • ストライエアルバエ（白）
    • 黒条線（黒）
    • ストライエカエルレア（ダークブルー）
  • ストレッチマークタイプ別：市場の魅力分析

第10章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 病院
    • 皮膚科クリニック
    • 美容クリニック
    • ウェルネス＆スパセンター
    • 在宅ケア環境
  • エンドユーザー別市場の魅力分析

第11章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 欧州市場分析

第15章 南アジア市場分析

第16章 東アジア市場分析

第17章 オセアニア市場分析

第18章 中東・アフリカ市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Weleda
    • Clarins
    • basq NYC
    • Body Merry
    • Himalaya Global Holdings Ltd.
    • Stratpharma AG（Stratpharma Inc.）
    • Browne Drug Co., Inc.（Palmer's）
    • Mederma（HRA Pharma）
    • Givaudan SA
    • NEOSTRATA COMPANY, INC.（Johnson &Johnson Services, Inc.）
    • Bio-Oil（Union Swiss（Pty）Ltd）
    • Merz Pharma
    • Dermaclara
    • Unilever

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP33375

Persistence Market Research has recently released a comprehensive report on the global stretch marks treatment market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Stretch Marks Treatment Market Size (2024E): USD 2.9 Billion
  • Projected Market Value (2033F): USD 4.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Stretch Marks Treatment Market - Report Scope:

Stretch marks, also known as striae or striae distensae, are a common skin condition that occurs due to rapid stretching of the skin. The stretch marks treatment market encompasses various therapeutic options, including topical treatments, laser therapies, and surgical interventions. These treatments aim to reduce the appearance of stretch marks and improve skin texture. The market serves a wide range of customers, including individuals seeking cosmetic improvements, healthcare providers offering specialized treatments, and aesthetic clinics providing advanced solutions. Market growth is driven by increasing awareness of skin aesthetics, rising prevalence of stretch marks due to lifestyle and hormonal changes, and advancements in treatment technologies.

Market Growth Drivers:

The global stretch marks treatment market is propelled by several key factors, including growing awareness about the availability of effective treatment options. Increasing instances of stretch marks due to factors such as pregnancy, rapid weight gain, and puberty contribute to the rising demand for treatments. Technological advancements, such as the development of non-invasive laser treatments and enhanced topical formulations, offer improved efficacy and patient comfort. Additionally, the increasing emphasis on aesthetic enhancements and cosmetic procedures is driving market expansion. The rise in disposable incomes and the growing trend of personalized skincare further contribute to market growth.

Market Restraints:

Despite promising growth prospects, the stretch marks treatment market faces challenges related to cost and accessibility. The high cost of advanced treatments, such as laser therapies and surgical interventions, can limit accessibility for some individuals. Additionally, the effectiveness of treatments can vary depending on individual skin types and the severity of the stretch marks, which may affect patient satisfaction and treatment outcomes. The market also encounters challenges related to regulatory compliance and the need for continued research to validate treatment efficacy and safety.

Market Opportunities:

The stretch marks treatment market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving consumer preferences. The integration of new technologies, such as radiofrequency and ultrasound-based treatments, offers enhanced treatment options. The increasing focus on personalized skincare solutions and the growing popularity of minimally invasive procedures create new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of affordable and effective treatments are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stretch marks treatment market globally?
  • Which treatment types and applications are driving adoption across different patient demographics?
  • How are technological advancements reshaping the competitive landscape of the stretch marks treatment market?
  • Who are the key players contributing to the stretch marks treatment market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global stretch marks treatment market?

Competitive Intelligence and Business Strategy:

Leading players in the global stretch marks treatment market, including Allergan PLC, Revance Therapeutics, Inc., and Syneron Candela, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment solutions, including novel topical agents, laser devices, and minimally invasive procedures. Collaborations with dermatologists, aesthetic clinics, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the dynamic stretch marks treatment landscape.

Key Companies Profiled:

  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer's)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Key Segments of Stretch Marks Treatment Industry Research

By Treatment:

  • Topical Medications
  • Procedural Treatments

By Stretch Mark Type:

  • Striae atrophicans (Thinned Skin)
  • Striae gravidarum (Post Pregnancy)
  • Striae distensae (Stretched Skin)
  • striae rubrae (Red)
  • Striae albae (White)
  • Striae nigra (Black)
  • Striae caerulea (Dark Blue)

By End User:

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics
  • Wellness and Spa Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe Stretch
  • South Asia Stretch
  • East Asia Stretch
  • Oceania Stretch
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Treatment Type Innovation / Development Trends

4. Key Success Factors

  • 4.1. Porter's Analysis
  • 4.2. PESTEL Analysis
  • 4.3. Dermatologists/Cosmetic Surgeons, Key Country
  • 4.4. Dermatology/Cosmetic Surgery Clinics, Key Country
  • 4.5. Number of Aesthetic Procedures, By Region
  • 4.6. Number of Pregnancy, By Region
  • 4.7. Payer Mix Analysis
  • 4.8. Promotional Strategies, By Key Players
  • 4.9. Healthcare Reimbursement and Financing Structure
  • 4.10. Regulatory Scenario
  • 4.11. Parent Market Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Life Expectancy Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Cases of Pregnancy
    • 5.2.2. Rising Disposable Per Capita Income
    • 5.2.3. Adoption of Aesthetic Treatments
    • 5.2.4. Changes in Lifestyle
    • 5.2.5. Shift from Invasive to Non-invasive Laser Therapies
    • 5.2.6. Presence of Highly Skilled Workforce
    • 5.2.7. Media Coverage and Awareness from Celebrities
    • 5.2.8. New/Improved Product Launches
    • 5.2.9. Growing Investment in Healthcare Expenditure
    • 5.2.10. Mergers and Acquisitions
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Treatment Type
    • 6.1.2. By Stretch Marks Type
    • 6.1.3. BY End User
    • 6.1.4. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Treatment Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Treatment Type, 2024-2033
    • 8.3.1. Topical Medications
      • 8.3.1.1. Gels
      • 8.3.1.2. Creams
      • 8.3.1.3. Oils/Serums
    • 8.3.2. Procedural Treatments
      • 8.3.2.1. Radiofrequency Therapy
      • 8.3.2.2. Nonablative Laser Fractional Resurfacing
      • 8.3.2.3. Ablative Laser Resurfacing
      • 8.3.2.4. Infrared Devices/Radiations
      • 8.3.2.5. Dermabrasion
      • 8.3.2.6. Chemical Peel
  • 8.4. Market Attractiveness Analysis By Treatment Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Stretch Marks Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Stretch Marks Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Stretch Marks Type, 2024-2033
    • 9.3.1. Striae Atrophicans (Thinned Skin)
    • 9.3.2. Striae Gravidarum (Post Pregnancy)
    • 9.3.3. Striae Distensae (Stretched Skin)
    • 9.3.4. Striae Rubrae (Red)
    • 9.3.5. Striae Albae (White)
    • 9.3.6. Striae Nigra (Black)
    • 9.3.7. Striae Caerulea (Dark Blue)
  • 9.4. Market Attractiveness Analysis By Stretch Marks Type

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Dermatology Clinics
    • 10.3.3. Aesthetic Clinics
    • 10.3.4. Wellness and Spa Centers
    • 10.3.5. Home Care Settings
  • 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Treatment Type
    • 12.3.3. By Stretch Marks Type
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Treatment Type
    • 12.4.3. By Stretch Marks Type
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Market Analysis
      • 12.5.1.1. .Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Treatment Type
        • 12.5.1.2.2. By Stretch Marks Type
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Treatment Type
        • 12.5.2.2.2. By Stretch Marks Type
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Stretch Marks Type
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Treatment Type
    • 13.4.3. By Stretch Marks Type
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Market Analysis
      • 13.5.1.1. .Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Treatment Type
        • 13.5.1.2.2. By Stretch Marks Type
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Treatment Type
        • 13.5.2.2.2. By Stretch Marks Type
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Treatment Type
        • 13.5.3.2.2. By Stretch Marks Type
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Bn) and Volume (Units) Forecast, By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Nordic Countries
      • 14.3.1.9. Rest of Europe
    • 14.3.2. By Treatment Type
    • 14.3.3. By Stretch Marks Type
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Treatment Type
    • 14.4.3. By Stretch Marks Type
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Market Analysis
      • 14.5.1.1. .Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Treatment Type
        • 14.5.1.2.2. By Stretch Marks Type
        • 14.5.1.2.3. By End User
    • 14.5.2. France Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Treatment Type
        • 14.5.2.2.2. By Stretch Marks Type
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Treatment Type
        • 14.5.3.2.2. By Stretch Marks Type
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Market Analysis
      • 14.5.4.1. .Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Treatment Type
        • 14.5.4.2.2. By Stretch Marks Type
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Market Analysis
      • 14.5.5.1. .Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Treatment Type
        • 14.5.5.2.2. By Stretch Marks Type
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Market Analysis
      • 14.5.6.1. .Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Treatment Type
        • 14.5.6.2.2. By Stretch Marks Type
        • 14.5.6.2.3. By End User
    • 14.5.7. Nordic Countries Market Analysis
      • 14.5.7.1. .Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Treatment Type
        • 14.5.7.2.2. By Stretch Marks Type
        • 14.5.7.2.3. By End User
    • 14.5.8. BENELUX Market Analysis
      • 14.5.8.1. .Introduction
      • 14.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.8.2.1. By Treatment Type
        • 14.5.8.2.2. By Stretch Marks Type
        • 14.5.8.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Treatment Type
    • 15.3.3. By Stretch Marks Type
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Treatment Type
    • 15.4.3. By Stretch Marks Type
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Market Analysis
      • 15.5.1.1. .Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Treatment Type
        • 15.5.1.2.2. By Stretch Marks Type
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Market Analysis
      • 15.5.2.1. .Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Treatment Type
        • 15.5.2.2.2. By Stretch Marks Type
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Treatment Type
        • 15.5.3.2.2. By Stretch Marks Type
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Treatment Type
        • 15.5.4.2.2. By Stretch Marks Type
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Treatment Type
    • 16.3.3. By Stretch Marks Type
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Treatment Type
    • 16.4.3. By Stretch Marks Type
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Market Analysis
      • 16.5.1.1. .Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Treatment Type
        • 16.5.1.2.2. By Stretch Marks Type
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Treatment Type
        • 16.5.2.2.2. By Stretch Marks Type
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Treatment Type
        • 16.5.3.2.2. By Stretch Marks Type
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Treatment Type
    • 17.3.3. By Stretch Marks Type
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Treatment Type
    • 17.4.3. By Stretch Marks Type
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Market Analysis
      • 17.5.1.1. .Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Treatment Type
        • 17.5.1.2.2. By Stretch Marks Type
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Treatment Type
        • 17.5.2.2.2. By Stretch Marks Type
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. Northern Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Treatment Type
    • 18.3.3. By Stretch Marks Type
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Treatment Type
    • 18.4.3. By Stretch Marks Type
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Market Analysis
      • 18.5.1.1. .Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Treatment Type
        • 18.5.1.2.2. By Stretch Marks Type
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkiye Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Treatment Type
        • 18.5.2.2.2. By Stretch Marks Type
        • 18.5.2.2.3. By End User
    • 18.5.3. Northern Africa Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Treatment Type
        • 18.5.3.2.2. By Stretch Marks Type
        • 18.5.3.2.3. By End User
    • 18.5.4. South Africa Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Treatment Type
        • 18.5.4.2.2. By Stretch Marks Type
        • 18.5.4.2.3. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Weleda
      • 20.3.1.1. Overview
      • 20.3.1.2. Treatment Type Portfolio
      • 20.3.1.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.1.4. Sales Footprint
      • 20.3.1.5. Strategy Overview
    • 20.3.2. Clarins
      • 20.3.2.1. Overview
      • 20.3.2.2. Treatment Type Portfolio
      • 20.3.2.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.2.4. Sales Footprint
      • 20.3.2.5. Strategy Overview
    • 20.3.3. basq NYC
      • 20.3.3.1. Overview
      • 20.3.3.2. Treatment Type Portfolio
      • 20.3.3.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.3.4. Sales Footprint
      • 20.3.3.5. Strategy Overview
    • 20.3.4. Body Merry
      • 20.3.4.1. Overview
      • 20.3.4.2. Treatment Type Portfolio
      • 20.3.4.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.4.4. Sales Footprint
      • 20.3.4.5. Strategy Overview
    • 20.3.5. Himalaya Global Holdings Ltd.
      • 20.3.5.1. Overview
      • 20.3.5.2. Treatment Type Portfolio
      • 20.3.5.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.5.4. Sales Footprint
      • 20.3.5.5. Strategy Overview
    • 20.3.6. Stratpharma AG (Stratpharma Inc.)
      • 20.3.6.1. Overview
      • 20.3.6.2. Treatment Type Portfolio
      • 20.3.6.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.6.4. Sales Footprint
      • 20.3.6.5. Strategy Overview
    • 20.3.7. Browne Drug Co., Inc. (Palmer's)
      • 20.3.7.1. Overview
      • 20.3.7.2. Treatment Type Portfolio
      • 20.3.7.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.7.4. Sales Footprint
      • 20.3.7.5. Strategy Overview
    • 20.3.8. Mederma (HRA Pharma)
      • 20.3.8.1. Overview
      • 20.3.8.2. Treatment Type Portfolio
      • 20.3.8.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.8.4. Sales Footprint
      • 20.3.8.5. Strategy Overview
    • 20.3.9. Givaudan SA
      • 20.3.9.1. Overview
      • 20.3.9.2. Treatment Type Portfolio
      • 20.3.9.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.9.4. Sales Footprint
      • 20.3.9.5. Strategy Overview
    • 20.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
      • 20.3.10.1. Overview
      • 20.3.10.2. Treatment Type Portfolio
      • 20.3.10.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.10.4. Sales Footprint
      • 20.3.10.5. Strategy Overview
    • 20.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
      • 20.3.11.1. Overview
      • 20.3.11.2. Treatment Type Portfolio
      • 20.3.11.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.11.4. Sales Footprint
      • 20.3.11.5. Strategy Overview
    • 20.3.12. Merz Pharma
      • 20.3.12.1. Overview
      • 20.3.12.2. Treatment Type Portfolio
      • 20.3.12.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.12.4. Sales Footprint
      • 20.3.12.5. Strategy Overview
    • 20.3.13. Dermaclara
      • 20.3.13.1. Overview
      • 20.3.13.2. Treatment Type Portfolio
      • 20.3.13.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.13.4. Sales Footprint
      • 20.3.13.5. Strategy Overview
    • 20.3.14. Unilever
      • 20.3.14.1. Overview
      • 20.3.14.2. Treatment Type Portfolio
      • 20.3.14.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.14.4. Sales Footprint
      • 20.3.14.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology